Literature DB >> 1649300

The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal.

M J Owens1, M A Vargas, D L Knight, C B Nemeroff.   

Abstract

Considerable evidence indicates that corticotropin-releasing factor (CRF) is responsible for integrating not only the endocrine, but the autonomic and behavioral responses of an organism to stress. We have investigated the time course of action of the anxiolytic triazolobenzodiazepine, alprazolam, on the activity of the hypothalamic-pituitary-adrenal (HPA) axis and of CRF neurons after acute and chronic administration. In addition, because many of the signs and symptoms observed in animals and humans after abrupt discontinuation of benzodiazepines resemble the stress response, we examined the effect of alprazolam withdrawal on CRF neurons and HPA axis activity. Alprazolam decreases CRF concentrations in the locus coeruleus between 0.5 and 3.0 h following acute injection. The half-life of alprazolam in rats is less than 1 h in both plasma and brain. Similarly, chronic (14 days) alprazolam administration also results in decreased CRF concentrations in the locus coeruleus. CRF concentrations return to control values 24 h after abrupt withdrawal. Moreover, abrupt alprazolam withdrawal results in increased plasma adrenocorticotrophic hormone and corticosterone concentrations and decreased anterior pituitary CRF receptor concentrations 24 h after drug discontinuation. These indices return to control values by 48 h postwithdrawal. These results support the hypothesis that both acute and chronic alprazolam administration alters CRF-containing neurons innervating the locus coeruleus. Additionally, abrupt alprazolam withdrawal profoundly activates the HPA axis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649300

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

Review 1.  Maternal programming of defensive responses through sustained effects on gene expression.

Authors:  Josie Diorio; Michael J Meaney
Journal:  J Psychiatry Neurosci       Date:  2007-07       Impact factor: 6.186

2.  Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems.

Authors:  K H Skelton; C B Nemeroff; D L Knight; M J Owens
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

3.  Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat.

Authors:  C Caldji; B Tannenbaum; S Sharma; D Francis; P M Plotsky; M J Meaney
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

4.  Sex-related elevation in cortisol during chronic treatment with alprazolam associated with enhanced cognitive performance.

Authors:  Nunzio Pomara; Lisa M Willoughby; James C Ritchie; John J Sidtis; David J Greenblatt; Charles B Nemeroff
Journal:  Psychopharmacology (Berl)       Date:  2005-10-19       Impact factor: 4.530

5.  Pharmacokinetics and bioavailability of midazolam after intravenous, subcutaneous, intraperitoneal and oral administration under a chronic food-limited regimen: relating DRL performance to pharmacokinetics.

Authors:  C E Lau; F Ma; Y Wang; C Smith
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

6.  Nicotinic activation of CRH neurons in extrahypothalamic regions of the rat brain.

Authors:  S G Matta; J D Valentine; B M Sharp
Journal:  Endocrine       Date:  1997-10       Impact factor: 3.633

Review 7.  Benzodiazepines and anterior pituitary function.

Authors:  E Arvat; R Giordano; S Grottoli; E Ghigo
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

Review 8.  Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: the role of the locus coeruleus.

Authors:  H Lehnert; C Schulz; K Dieterich
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

9.  Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders.

Authors:  J D Coplan; M W Andrews; L A Rosenblum; M J Owens; S Friedman; J M Gorman; C B Nemeroff
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-20       Impact factor: 11.205

10.  Alprazolam, caffeine and their interaction: relating DRL performance to pharmacokinetics.

Authors:  C E Lau; J Wang
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.